Novanta Inc. (NOVT)

Market Cap	4.04B
Revenue (ttm)	960.31M
Net Income (ttm)	52.82M
Shares Out	35.78M
EPS (ttm)	1.46
PE Ratio	77.36
Forward PE	32.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	410,062
Open	111.35
Previous Close	111.89
Day's Range	111.16 - 113.60
52-Week Range	98.27 - 173.41
Beta	1.59
Analysts	Hold
Price Target	133.00 (+17.75%)
Earnings Date	Nov 3, 2025

About NOVT

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1968
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: NOVT
• Website: https://www.novanta.com

Financial Performance

In 2024, Novanta's revenue was $949.25 million, an increase of 7.67% compared to the previous year's $881.66 million. Earnings were $64.09 million, a decrease of -12.06%.

Analyst Summary

According to one analyst, the rating for NOVT stock is "Hold" and the 12-month stock price target is $133.0.

Price Target

$133.0

(17.75% upside)

Analyst Consensus: Hold